Wednesday, June 05, 2024 Stewart DA, Kuruvilla J, Lee D, Dudebout JJ, Chua N, Larouche J-F, Baetz T, Shafey M, Abdel-Samad N, Robinson S, Fleury I, Fraser G, Skrabek P, Kukreti V, Kelly J, Hay AE, Shepherd LE, Chen BE, Crump M. Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre-autologous stem cell transplant in relapsed/refractory diffuse large B-cell lymphoma—outcome of rituximab-dose-intensive cyclophosphamide, etoposide, cisplatin (R-DICEP) versus R-GDP (ONLINE). British Journal of Haematology 2024. https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.19555
